Skip to main content
  • 544 Accesses

Abstract

Human mast cells (MCs) are classified into two phenotypes as to whether they contain detectable levels of chymase in their granules. MCs having chymase at high levels (MCTC) can respond to substance P and C5a, whereas MCs lacking detectable chymase (MCT) can respond to platelet-activating factors. While these MC phenotypes can be maintained over weeks when cultured in the standard culture condition supplemented with SCF and IL-6, MCTC lose chymase when they are cultured in the presence of culture supernatant obtained from IL-13-stimulated airway epithelial cells. MCs trigger not only the immediate-type allergic reaction in an IgE-mediated manner but also the late-phase allergic response and chronic allergic inflammation. However, it is necessary to consider the relative role of MCs in allergic or innate-type inflammation by understanding cytokines/chemokines produced by other immune cell types and epithelial-mesenchymal tissues. The expression of these cytokines is almost completely blocked when glucocorticoid and FK506 are added simultaneously into the reaction buffer for MC activation. It would be difficult to surpass this effect even if we could develop a new anti-MC drug.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

CPA3:

Carboxypeptidase A3

cys-LT:

Cysteinyl leukotriene

FcεRI:

High-affinity receptor for IgE

GC:

Glucocorticoid

GM-CSF:

Granulocyte-macrophage colony-stimulating factor

IL:

Interleukin

MCs:

Mast cells

MCT:

T-type mast cells

MCTC:

TC-type mast cells

MIP:

Macrophage inflammatory protein

NFAT:

Nuclear factor-activated T

NF-κB:

Nuclear factor-κB

PAF:

Platelet-activating factor

PGD2:

Prostaglandin D2

SCF:

Stem cell factor

TLR :

Toll-like receptor

TNF-α:

Tumor necrosis factor

TSLP:

Thymic stromal lymphopoietin

References

  1. Bradding P, Saito H. Biology of mast cells and their mediators. In: Adkinson F, Bochner BS, Burks AW, Holgate ST, Lemanske RF, O’Hehir R, editors. Middleton’s allergy: principles and practice, vol. 1. 8th ed. Philadelphia, PA: Elsevier Saunders; 2013. p. 228–51.

    Google Scholar 

  2. Kitamura Y, Go S, Hatanaka K. Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation. Blood. 1978;52:447–52.

    Article  CAS  PubMed  Google Scholar 

  3. Kitamura Y, Go S. Decreased production of mast cells in S1/S1d anemic mice. Blood. 1979;53:492–7.

    Article  CAS  PubMed  Google Scholar 

  4. Kitamura Y, Shimada M, Hatanaka K, Miyano Y. Development of mast cells from grafted bone marrow cells in irradiated mice. Nature. 1977;268:442–3.

    Article  CAS  PubMed  Google Scholar 

  5. Befus AD, Pearce FL, Gauldie J, Horsewood P, Bienenstock J. Mucosal mast cells. I. Isolation and functional characteristics of rat intestinal mast cells. J Immunol. 1982;128:2475.

    Article  CAS  PubMed  Google Scholar 

  6. Pearce FL, Befus AD, Gauldie J, Bienenstock J. Mucosal mast cells. II. Effects of anti-allergic compounds on histamine secretion by isolated intestinal mast cells. J Immunol. 1982;128:2481.

    Article  CAS  PubMed  Google Scholar 

  7. Ihle JN, Keller J, Oroszlan S, Henderson LE, Copeland TD, Fitch F, Prystowsky MB, Goldwasser E, Schrader JW, Palaszynski E, Dy M, Lebel B. Biologic properties of homogeneous interleukin 3. I. Demonstration of WEHI-3 growth factor activity, mast cell growth factor activity, p cell-stimulating factor activity, colony-stimulating factor activity, and histamine-producing cell-stimulating factor activity. J Immunol. 1983;131:282–7.

    Article  CAS  PubMed  Google Scholar 

  8. Saito H, Hatake K, Dvorak AM, Leiferman KM, Donnenberg AD, Arai N, Ishizaka K, Ishizaka T. Selective differentiation and proliferation of hematopoietic cells induced by recombinant human interleukins. Proc Natl Acad Sci U S A. 1988;85:2288–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Miyajima A. Molecular structure of the IL-3, GM-CSF and IL-5 receptors. Int J Cell Cloning. 1992;10:126–34.

    Article  CAS  PubMed  Google Scholar 

  10. Irani AMA, Schecter NM, Craig SS, DeBlois G, Schwartz LB. Two types of human mast cells that have distinct neutral protease compositions. Proc Natl Acad Sci U S A. 1986;83:4464–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Enerback L, Pipkorn U, Olofsson A. Intraepithelial migration of mucosal mast cells in hay fever. Int Arch Allergy Appl Immunol. 1986;80:44.

    Article  CAS  PubMed  Google Scholar 

  12. Pawankar R, Ra C. Heterogeneity of mast cells and T cells in the nasal mucosa. J Allergy Clin Immunol. 1996;98:249.

    Article  Google Scholar 

  13. Dougherty RH, Sidhu SS, Raman K, Solon M, Solberg OD, Caughey GH, Woodruff PG, Fahy JV. Accumulation of intraepithelial mast cells with a unique protease phenotype in TH2-high asthma. J Allergy Clin Immunol. 2010;125:1046–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Corren J, Lemanske RF, Hanania NA, Korenblat PE, Parsey MV, Arron JR, Harris JM, Scheerens H, Wu LC, Su Z, Mosesova S, Eisner MD, Bohen SP, Matthews JG. Lebrikizumab treatment in adults with asthma. N Engl J Med. 2011;365:1088–98.

    Article  CAS  PubMed  Google Scholar 

  15. Kashiwakura J, Yokoi H, Saito H, Okayama Y. T cell proliferation by direct cross-talk between OX40 ligand on human mast cells and OX40 on human T cells: comparison of gene expression profiles between human tonsillar and lung-cultured mast cells. J Immunol. 2004;173:5247–57.

    Article  CAS  PubMed  Google Scholar 

  16. Takabayashi T, Kato A, Peters AT, Suh LA, Carter R, Norton J, Grammer LC, Tan BK, Chandra RK, Conley DB, Kern RC, Fujieda S, Schleimer RP. Glandular mast cells with distinct phenotype are highly elevated in chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2012;130:410–20.e5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Kajiwara N, Sasaki T, Bradding P, Cruse G, Sagara H, Ohmori K, Saito H, Ra C, Okayama Y. Activation of human mast cells through the platelet-activating factor receptor. J Allergy Clin Immunol. 2010;125:1137–45.

    Article  CAS  PubMed  Google Scholar 

  18. Nakajima T, Inagaki N, Tanaka H, Tanaka A, Yoshikawa M, Tamari M, Hasegawa K, Matsumoto K, Tachimoto H, Ebisawa M, Tsujimoto G, Matsuda H, Nagai H, Saito H. Marked increase in CC chemokine gene expression in both human and mouse mast cell transcriptomes following Fcε receptor I cross-linking: an interspecies comparison. Blood. 2002;100:3861–8.

    Article  CAS  PubMed  Google Scholar 

  19. Brightling CE, Bradding P, Symon FA, Holgate ST, Wardlaw AJ, Pavord ID. Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med. 2002;346:1699–705.

    Article  PubMed  Google Scholar 

  20. Bischoff SC. Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data. Nat Rev Immunol. 2007;7:93–104.

    Article  CAS  PubMed  Google Scholar 

  21. Bradding P, Feather IH, Howarth PH, Mueller R, Roberts JA, Britten K, Bews JP, Hunt TC, Okayama Y, Heusser CH, Bullock GR, Church MK, Holgate ST. Interleukin 4 is localized to and released by human mast cells. J Exp Med. 1992;176:1381–6.

    Article  CAS  PubMed  Google Scholar 

  22. Pawankar R, Okuda M, Yssel H, Okumura K, Ra C. Nasal mast cells in perennial allergic rhinitics exhibit increased expression of the fc epsilonRI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells. J Clin Invest. 1997;99:1492–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Mukai K, Mindy T, Saito H, Galli S. Mast cells as sources of cytokines, chemokines and growth factors. Immunol Rev. 2018;282:121–50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Moro K, Yamada T, Tanabe M, Takeuchi T, Ikawa T, Kawamoto H, et al. Innate production of T(H)2 cytokines by adipose tissue-associated c-kit(+)Sca-1(+) lymphoid cells. Nature. 2010;463:540–4.

    Article  CAS  PubMed  Google Scholar 

  25. Morita H, Moro K, Koyasu S. Innate lymphoid cells in allergic and nonallergic inflammation. J Allergy Clin Immunol. 2016;138:1253–64.

    Article  CAS  PubMed  Google Scholar 

  26. Iikura M, Suto H, Kajiwara N, Oboki K, Ohno T, Okayama Y, Saito H, Galli SJ, Nakae S. IL-33 can promote survival, adhesion and cytokine production in human mast cells. Lab Investig. 2007;87:971–8.

    Article  CAS  PubMed  Google Scholar 

  27. Krämer S, Sellge G, Lorentz A, Krueger D, Schemann M, Feilhauer K, Gunzer F, Bischoff SC. Selective activation of human intestinal mast cells by Escherichia coli hemolysin. J Immunol. 2008;181:1438–45.

    Article  PubMed  Google Scholar 

  28. Nakajima S, Krishnan B, Ota H, Segura AM, Hattori T, Graham DY, Genta RM. Mast cell involvement in gastritis with or without helicobacter pylori infection. Gastroenterology. 1997;113:746–54.

    Article  CAS  PubMed  Google Scholar 

  29. Supajatura V, Ushio H, Nakao A, Akira S, Okumura K, Ra C, Ogawa H. Differential responses of mast cell toll-like receptors 2 and 4 in allergy and innate immunity. J Clin Invest. 2002;109:1351–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Okumura S, Kashiwakura J, Tomita H, Matsumoto K, Nakajima T, Saito H, Okayama Y. Identification of specific gene expression profile in human mast cells via toll-like receptor 4 and FcεRI. Blood. 2003;102:2547–54.

    Article  CAS  PubMed  Google Scholar 

  31. Kato A, Chustz RT, Ogasawara T, Kulka M, Saito H, Schleimer RP, Matsumoto K. Dexamethasone and FK506 inhibit expression of distinct subsets of chemokines in human mast cells. J Immunol. 2009;182:7233–43.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hirohisa Saito .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Saito, H. (2023). Mast Cells. In: Celebi, Ö.Ö., Önerci, T.M. (eds) Nasal Physiology and Pathophysiology of Nasal Disorders. Springer, Cham. https://doi.org/10.1007/978-3-031-12386-3_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-12386-3_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-12385-6

  • Online ISBN: 978-3-031-12386-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics